Explore the latest in neuro-oncology, including advances in diagnosis and management of glial tumors, CNS lymphomas, and CNS metastases.
In this narrative medicine essay a cardiologist with a previously treated astrocytoma describes his thoughts and fears of managing a tumor recurrence when he experiences frightening symptoms during the COVID-19 pandemic.
This article presents the case of a woman who developed gradual visual field loss after taking chloroquine as part of treatment for glioblastoma multiforme.
This randomized clinical trial compares overall survival for patients receiving tumor resection followed by vocimagene amiretrorepvec (Toca 511) with flucytosine (Toca FC) vs standard of care.
This cohort study evaluates the national practice patterns of MGMT gene testing and identified potential factors associated with access to testing.
This cohort study looks at outcomes and prognostic factors associated with overall survival and local control after hypofractionated stereotactic radiotherapy to the resection cavity of patients with brain metastases.
This case series evaluates pembrolizumab concentrations and programmed cell death 1 blockade on T cells in cerebrospinal fluid after intravenous administration.
This comparative effectiveness study explores the association of immunotherapy with overall survival in patients with cancer and brain metastases who received definitive surgery of the primary tumor site.
This cohort study examines the association of molecular alterations in cerebrospinal fluid (CSF) with the survival of patients with a diagnosis of lung adenocarcinoma and central nervous system (CNS) metastases.
This cohort study examines the association of innovations in radiotherapy techniques and systemic treatment with clinical outcomes among Canadian patients with melanoma brain metastasis between 2007 and 2016.
This Viewpoint advocates for the consideration of hippocampal-sparing radiotherapy in patients with gliomas to mitigate treatment-related adverse events.
This randomized clinical trial examines the effect of programmed cell death 1 immune checkpoint inhibition with nivolumab on overall survival for patients with recurrent glioblastoma.
This cohort study compares the overall survival, disease progression, and other outcomes of stereotactic radiosurgery with those of whole-brain radiotherapy in patients with brain metastases from small cell lung cancer.
This secondary analysis of data from the HERACLES-A clinical trial examines long-term outcomes in 32 patients with colorectal cancer treated with trastuzumab and lapatinib.
This cohort study examines outcomes of patients with brain cancer to provide demographic details on the increase in suicide rate after brain cancer diagnosis.
This multicenter cohort study assesses the association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival among patients with newly diagnosed glioblastoma in different molecular subgroups to develop a new road map for cytoreductive surgery.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: